AAWH 1 (-4.76%)
US04351N1063Drug ManufacturersDrug Manufacturers - Specialty & Generic

Ascend Wellness Holdings (AAWH) Competitor Comparison

We are evaluating the key criteria listed to compare Ascend Wellness Holdings (AAWH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - AAWH ranking 43 / 54

These are the competitors of Ascend Wellness Holdings in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. ProPhase Labs PRPH
57.77
2. Zoetis ZTS
55.89
3. Supernus Pharmaceuticals SUPN
27.89
4. Kamada KMDA
19.5
5. Kolinpharma KIP.MI
11.59
6. Evolus EOLS
10.62
7. Regencell Bioscience Holdings RGC
9.11
8. Amneal Pharmaceuticals AMRX
9.01
9. Vifor Pharma G2AB.F
6.24
10. Perrigo PRGO
5.06
11. Ironwood Pharmaceuticals IRWD
5
12. Phibro Animal Health PAHC
4.54
13. Cumberland Pharmaceuticals CPIX
4.4
14. Catalent CTLT
4.14
15. Pacira BioSciences PCRX
4.07
16. Taro Pharmaceutical Industries TARO
4
17. Alvotech ALVO
3.62
18. Collegium Pharmaceutical COLL
3.5
19. Linc LNC
3.36
20. Zynerba Pharmaceuticals ZYNE
3
21. Elanco Animal Health ELAN
3
22. Green Thumb Industries R9U2.F
2.79
23. PetIQ PETQ
2.74
24. Procaps Group PROC
2.74
25. Eagle Pharmaceuticals EGRX
2.72
26. Embecta EMBC
2.6
27. OptiNose OPTN
2.55
28. Societal CDMO SCTL
2.41
29. ANI Pharmaceuticals ANIP
2.27
30. Curaleaf Holdings CURLF
2.25
31. Alimera Sciences ALIM
2.2
32. Teva Pharmaceutical Industries TEVA
2.12
33. Journey Medical DERM
2.11
34. Theratechnologies THTX
2.1
35. Bausch Health Companies BHC
2.07
36. Cronos Group CRON
2.05
37. Amphastar Pharmaceuticals AMPH
2
38. SCYNEXIS SCYX
1.93
39. Emergent BioSolutions EBS
1.86
40. Relmada Therapeutics RLMD
1.85
41. Jupiter Wellness JUPW
1.84
42. Organogenesis Holdings ORGO
1.78
43. Ascend Wellness Holdings AAWH
1.78
44. Harrow Health HROW
1.77
45. Flora Growth FLGC
1.76
46. Universe Pharmaceuticals UPC
1.75
47. Alpha Teknova TKNO
1.74
48. Tilray Brands TLRY
1.69
49. Biofrontera BFRI
1.69
50. Clever Leaves Holdings CLVR
1.66
51. Ayr Wellness 3KJB.F
1.63
52. Solid Biosciences SLDB
1.6
53. Neoleukin Therapeutics NLTX
1.57
54. Avadel Pharmaceuticals AVDL
1.41

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.